Magnetar Financial LLC Kodiak Sciences Inc. Transaction History

Magnetar Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$81.97 - $106.94 $238,860 - $311,623	-2,914 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$77.2 - $126.54 $224,960 - $368,737	2,914 New	2,914 $271,000
Q1 2021 May 14, 2021	SELL	$110.45 - $164.47 $211,069 - $314,302	-1,911 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$60.78 - $154.03 $116,150 - $294,351	1,911 New	1,911 $281,000

101

38.8M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $289M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.